Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Europe Stands Firm On Nitrosamine Assessment Deadline For APIs
Companies Can Suggest New Timeline In Justified Cases
Aug 21 2020
•
By
Vibha Sharma
Nitrosamine impurities have been found in marketed medicines in the recent past • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Europe
More from Geography